Literature DB >> 20497048

Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA.

M Christine Zink1, Angela K Brice, Kathleen M Kelly, Suzanne E Queen, Lucio Gama, Ming Li, Robert J Adams, Christopher Bartizal, John Varrone, S Alireza Rabi, David R Graham, Patrick M Tarwater, Joseph L Mankowski, Janice E Clements.   

Abstract

BACKGROUND: During the era of highly active antiretroviral therapy (HAART), the prevalence of HIV-associated central nervous system (CNS) disease has increased despite suppression of plasma viremia.
METHODS: In a simian immunodeficiency virus (SIV) model system in which all animals develop AIDS and 90% develop CNS disease by 3 months after inoculation, pigtailed macaques were treated with a regimen of tenofovir disoproxil fumarate, saquinavir, atazanavir, and an integrase inhibitor starting at 12 days after inoculation and were euthanized at approximately 175 days after inoculation.
RESULTS: Plasma and cerebrospinal fluid (CSF) viral loads declined rapidly after the initiation of HAART. Brain viral RNA was undetectable at necropsy, but viral DNA levels were not different from those in untreated SIV-infected macaques. CNS inflammation was significantly reduced, with decreased brain expression of major histocompatibility complex class II and glial fibrillary acidic protein and reduced levels of CSF CCL2 and interleukin 6. Brain from treated macaques had significantly lower levels of interferon beta, type 1 interferon-inducible gene myxovirus (influenza) resistance A, and indolamine 2,3-dioxygenase messenger RNA, suggesting that immune hyperactivation was suppressed, and fewer CD4(+) and CD8(+) T cells, suggesting that trafficking of T cells from peripheral blood was reduced. Brain levels of CD68 protein and tumor necrosis factor alpha and interferon gamma RNA were reduced but were not significantly lower, indicating continued CNS inflammation.
CONCLUSIONS: These data, generated in a rigorous, high-viral-load SIV-infected macaque model, showed that HAART provided benefits with respect to CNS viral replication and inflammation but that no change in the level of viral DNA and continued CNS inflammation occurred in some macaques.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20497048      PMCID: PMC2880623          DOI: 10.1086/653213

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

1.  Tenofovir-related nephrotoxicity in HIV-infected patients.

Authors:  Ana Barrios; Teresa García-Benayas; Juan González-Lahoz; Vincent Soriano
Journal:  AIDS       Date:  2004-04-09       Impact factor: 4.177

2.  Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin.

Authors:  Richard W Price; Robin Parham; Jing Lu Kroll; Stephen A Wring; Brian Baker; Jeff Sailstad; Rebecca Hoh; Teri Liegler; Serena Spudich; Daniel R Kuritzkes; Steven G Deeks
Journal:  Antivir Ther       Date:  2008

3.  Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.

Authors:  M C Zink; G D Coleman; J L Mankowski; R J Adams; P M Tarwater; K Fox; J E Clements
Journal:  J Infect Dis       Date:  2001-09-10       Impact factor: 5.226

Review 4.  Immunopathogenesis and immunotherapy in AIDS virus infections.

Authors:  Norman L Letvin; Bruce D Walker
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

5.  Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.

Authors:  Daria J Hazuda; Steven D Young; James P Guare; Neville J Anthony; Robert P Gomez; John S Wai; Joseph P Vacca; Larry Handt; Sherri L Motzel; Hilton J Klein; Geethanjali Dornadula; Robert M Danovich; Marc V Witmer; Keith A A Wilson; Lynda Tussey; William A Schleif; Lori S Gabryelski; Lixia Jin; Michael D Miller; Danilo R Casimiro; Emilio A Emini; John W Shiver
Journal:  Science       Date:  2004-07-08       Impact factor: 47.728

6.  Impaired performance on a rhesus monkey neuropsychological testing battery following simian immunodeficiency virus infection.

Authors:  Michael R Weed; Lisa H Gold; Ilham Polis; George F Koob; Howard S Fox; Michael A Taffe
Journal:  AIDS Res Hum Retroviruses       Date:  2004-01       Impact factor: 2.205

7.  Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model.

Authors:  Sheila A Barber; Lucio Gama; Justyna M Dudaronek; Tauni Voelker; Patrick M Tarwater; Janice E Clements
Journal:  J Infect Dis       Date:  2006-02-21       Impact factor: 5.226

8.  Regulation of tristetraprolin expression by interleukin-1 beta and dexamethasone in human pulmonary epithelial cells: roles for nuclear factor-kappa B and p38 mitogen-activated protein kinase.

Authors:  Elizabeth M King; Manminder Kaur; Wei Gong; Christopher F Rider; Neil S Holden; Robert Newton
Journal:  J Pharmacol Exp Ther       Date:  2009-05-12       Impact factor: 4.030

9.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Authors:  Scott Letendre; Jennifer Marquie-Beck; Edmund Capparelli; Brookie Best; David Clifford; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; Susan Morgello; David Simpson; Igor Grant; Ronald J Ellis
Journal:  Arch Neurol       Date:  2008-01

10.  Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV.

Authors:  Payam Tabarsi; Ali S Saber-Tehrani; Parvaneh Baghaei; Mojgan Padyab; Davood Mansouri; Majid Amiri; Mohammad Reza Masjedi; Frederick L Altice
Journal:  J Int AIDS Soc       Date:  2009-07-16       Impact factor: 5.396

View more
  76 in total

Review 1.  Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

Authors:  K Grovit-Ferbas; M E Harris-White
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  Persistent Peripheral Nervous System Damage in Simian Immunodeficiency Virus-Infected Macaques Receiving Antiretroviral Therapy.

Authors:  Jamie L Dorsey; Lisa M Mangus; Peter Hauer; Gigi J Ebenezer; Suzanne E Queen; Victoria A Laast; Robert J Adams; Joseph L Mankowski
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

3.  Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy.

Authors:  G Matusali; N Dereuddre-Bosquet; A Le Tortorec; M Moreau; A-P Satie; D Mahé; P Roumaud; O Bourry; N Sylla; S Bernard-Stoecklin; A Pruvost; R Le Grand; N Dejucq-Rainsford
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

4.  Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy.

Authors:  Stefanie Perez; Ann-Marie Johnson; Shi-Hua Xiang; Jian Li; Brian T Foley; Lara Doyle-Meyers; Antonito Panganiban; Amitinder Kaur; Ronald S Veazey; Yuntao Wu; Binhua Ling
Journal:  J Neurovirol       Date:  2017-11-27       Impact factor: 2.643

Review 5.  Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?

Authors:  Heather Carryl; Melanie Swang; Jerome Lawrence; Kimberly Curtis; Herman Kamboj; Koen K A Van Rompay; Kristina De Paris; Mark W Burke
Journal:  ACS Chem Neurosci       Date:  2015-06-19       Impact factor: 4.418

6.  Editor's Commentary for Special Issue: "The Role of Macrophages in HIV Persistence".

Authors:  Tricia H Burdo
Journal:  J Neuroimmune Pharmacol       Date:  2019-02-09       Impact factor: 4.147

7.  Modeling brain lentiviral infections during antiretroviral therapy in AIDS.

Authors:  Weston C Roda; Michael Y Li; Michael S Akinwumi; Eugene L Asahchop; Benjamin B Gelman; Kenneth W Witwer; Christopher Power
Journal:  J Neurovirol       Date:  2017-05-16       Impact factor: 2.643

Review 8.  Overcoming pharmacologic sanctuaries.

Authors:  Theodore J Cory; Timothy W Schacker; Mario Stevenson; Courtney V Fletcher
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

9.  Giant cell encephalitis and microglial infection with mucosally transmitted simian-human immunodeficiency virus SHIVSF162P3N in rhesus macaques.

Authors:  Carole Harbison; Ke Zhuang; Agegnehu Gettie; James Blanchard; Heather Knight; Peter Didier; Cecilia Cheng-Mayer; Susan Westmoreland
Journal:  J Neurovirol       Date:  2014-01-25       Impact factor: 2.643

10.  Loss of a tyrosine-dependent trafficking motif in the simian immunodeficiency virus envelope cytoplasmic tail spares mucosal CD4 cells but does not prevent disease progression.

Authors:  Matthew W Breed; Andrea P O Jordan; Pyone P Aye; Cornelis F Lichtveld; Cecily C Midkiff; Faith R Schiro; Beth S Haggarty; Chie Sugimoto; Xavier Alvarez; Netanya G Sandler; Daniel C Douek; Marcelo J Kuroda; Bapi Pahar; Michael Piatak; Jeffrey D Lifson; Brandon F Keele; James A Hoxie; Andrew A Lackner
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.